• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双重可编程半导体聚合物纳米 PROTAC 用于深层组织声动力学铁死亡激活免疫治疗。

Dual-Programmable Semiconducting Polymer NanoPROTACs for Deep-Tissue Sonodynamic-Ferroptosis Activatable Immunotherapy.

机构信息

State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Biological Science and Medical Engineering, Donghua University, Shanghai, 201620, China.

School of Pharmacy, Second Military Medical University, Shanghai, 200433, China.

出版信息

Small. 2024 Feb;20(8):e2306378. doi: 10.1002/smll.202306378. Epub 2023 Oct 10.

DOI:10.1002/smll.202306378
PMID:37817359
Abstract

Proteolysis-targeting chimeras (PROTACs) can provide promising opportunities for cancer treatment, while precise regulation of their activities remains challenging to achieve effective and safe therapeutic outcomes. A semiconducting polymer nanoPROTAC (SPN ) is reported that can achieve ultrasound (US) and tumor microenvironment dual-programmable PROTAC activity for deep-tissue sonodynamic-ferroptosis activatable immunotherapy. SPN is formed through a nano-precipitation of a sonodynamic semiconducting polymer, a ferroptosis inducer, and a newly synthesized PROTAC molecule. The semiconducting polymers work as sonosensitizers to produce singlet oxygen ( O ) via sonodynamic effect under US irradiation, and ferroptosis inducers react with intratumoral hydrogen peroxide (H O ) to generate hydroxyl radical (·OH). Such a dual-programmable reactive oxygen species (ROS) generation not only triggers ferroptosis and immunogenic cell death (ICD), but also induces on-demand activatable delivery of PROTAC molecules into tumor sites. The effectively activated nanoPROTACs degrade nicotinamide phosphoribosyl transferase (NAMPT) to suppress tumor infiltration of myeloid-derived suppressive cells (MDSCs), thus promoting antitumor immunity. In such a way, SPN mediates sonodynamic-ferroptosis activatable immunotherapy for entirely inhibiting tumor growths in both subcutaneous and 2-cm tissue-covered deep tumor mouse models. This study presents a dual-programmable activatable strategy based on PROTACs for effective and precise cancer combinational therapy.

摘要

蛋白水解靶向嵌合体(PROTACs)可为癌症治疗提供有前景的机会,而精确调控其活性对于实现有效和安全的治疗效果仍然具有挑战性。本文报道了一种半导体聚合物纳米 PROTAC(SPN),它可以实现超声(US)和肿瘤微环境的双重可编程 PROTAC 活性,用于深组织声动力学-铁死亡激活免疫治疗。SPN 通过超声处理下的声敏半导体聚合物、铁死亡诱导剂和新合成的 PROTAC 分子的纳米沉淀形成。半导体聚合物作为声敏剂,通过声动力学效应产生单线态氧(1 O 2 ),铁死亡诱导剂与肿瘤内的过氧化氢(H 2 O 2 )反应生成羟基自由基(·OH)。这种双重可编程活性氧(ROS)的产生不仅触发铁死亡和免疫原性细胞死亡(ICD),还能按需将 PROTAC 分子递送到肿瘤部位。有效激活的纳米 PROTAC 降解烟酰胺磷酸核糖转移酶(NAMPT),抑制髓系来源抑制细胞(MDSCs)浸润肿瘤,从而促进抗肿瘤免疫。通过这种方式,SPN 介导了声动力学-铁死亡激活免疫治疗,完全抑制了皮下和 2cm 组织覆盖的深部肿瘤小鼠模型中的肿瘤生长。本研究提出了一种基于 PROTAC 的双重可编程激活策略,用于有效的癌症联合治疗。

相似文献

1
Dual-Programmable Semiconducting Polymer NanoPROTACs for Deep-Tissue Sonodynamic-Ferroptosis Activatable Immunotherapy.双重可编程半导体聚合物纳米 PROTAC 用于深层组织声动力学铁死亡激活免疫治疗。
Small. 2024 Feb;20(8):e2306378. doi: 10.1002/smll.202306378. Epub 2023 Oct 10.
2
Augmenting Immunogenic Cell Death and Alleviating Myeloid-Derived Suppressor Cells by Sono-Activatable Semiconducting Polymer Nanopartners for Immunotherapy.声敏半导体聚合物纳米伴侣通过增强免疫原性细胞死亡和缓解髓系来源抑制细胞来进行免疫治疗。
Adv Mater. 2023 Aug;35(33):e2302508. doi: 10.1002/adma.202302508. Epub 2023 Jul 2.
3
Sono-Activatable Semiconducting Polymer Nanoreshapers Multiply Remodel Tumor Microenvironment for Potent Immunotherapy of Orthotopic Pancreatic Cancer.声敏型半导体聚合物纳米重塑剂可多次重塑肿瘤微环境,增强原位胰腺癌的免疫治疗效果。
Adv Sci (Weinh). 2023 Dec;10(35):e2305150. doi: 10.1002/advs.202305150. Epub 2023 Oct 23.
4
Activatable Semiconducting Polymer Pro-nanomodulators for Deep-Tissue Sono-immunotherapy of Orthotopic Pancreatic Cancer.用于原位胰腺癌的深组织声免疫治疗的可激活半导体聚合物前纳米调节剂。
Angew Chem Int Ed Engl. 2023 Jul 24;62(30):e202305200. doi: 10.1002/anie.202305200. Epub 2023 Jun 6.
5
Semiconducting polymer nanoprodrugs enable tumor-specific therapy via sono-activatable ferroptosis.半导体聚合物纳米前药通过声激活的铁死亡实现肿瘤特异性治疗。
Biomaterials. 2025 Jan;312:122722. doi: 10.1016/j.biomaterials.2024.122722. Epub 2024 Jul 29.
6
Activatable Semiconducting Polymer Nanoinducers Amplify Oxidative Damage via Sono-Ferroptosis for Synergistic Therapy of Bone Metastasis.声动力铁死亡型纳米引发剂通过激活半导体聚合物放大氧化损伤用于协同治疗骨转移
Nano Lett. 2023 Aug 23;23(16):7699-7708. doi: 10.1021/acs.nanolett.3c02414. Epub 2023 Aug 11.
7
Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy.用于光免疫代谢癌症治疗的半导体聚合物纳米-PROTACs。
Nat Commun. 2021 May 18;12(1):2934. doi: 10.1038/s41467-021-23194-w.
8
Precision cancer sono-immunotherapy using deep-tissue activatable semiconducting polymer immunomodulatory nanoparticles.使用深部激活半导体聚合物免疫调节纳米颗粒的精准癌症声免疫治疗。
Nat Commun. 2022 Jul 12;13(1):4032. doi: 10.1038/s41467-022-31551-6.
9
Activatable Cancer Sono-Immunotherapy using Semiconducting Polymer Nanobodies.基于半导体聚合物纳米抗体的肿瘤激活型声敏免疫治疗
Adv Mater. 2022 Jul;34(28):e2203246. doi: 10.1002/adma.202203246. Epub 2022 Jun 6.
10
Prodrug-loaded semiconducting polymer hydrogels for deep-tissue sono-immunotherapy of orthotopic glioblastoma.载前药的半导体聚合物水凝胶用于原位脑胶质瘤的深组织声免疫治疗。
Biomater Sci. 2023 Oct 10;11(20):6823-6833. doi: 10.1039/d3bm00585b.

引用本文的文献

1
Mechanism of Ferroptosis and Its Role in Disease Development.铁死亡的机制及其在疾病发展中的作用。
Int J Biol Sci. 2025 Aug 22;21(12):5328-5360. doi: 10.7150/ijbs.102859. eCollection 2025.
2
Synergistic Ferroptosis-Immunotherapy Nanoplatforms: Multidimensional Engineering for Tumor Microenvironment Remodeling and Therapeutic Optimization.协同铁死亡-免疫疗法纳米平台:用于肿瘤微环境重塑和治疗优化的多维工程
Nanomicro Lett. 2025 Sep 2;18(1):56. doi: 10.1007/s40820-025-01862-6.
3
Recent Advances in Nanomedicine: Cutting-Edge Research on Nano-PROTAC Delivery Systems for Cancer Therapy.
纳米医学的最新进展:用于癌症治疗的纳米PROTAC递送系统的前沿研究
Pharmaceutics. 2025 Aug 10;17(8):1037. doi: 10.3390/pharmaceutics17081037.
4
MMP-2-triggered, mitochondria-targeted PROTAC-PDT therapy of breast cancer and brain metastases inhibition.MMP-2 触发的线粒体靶向 PROTAC-PDT 治疗乳腺癌和脑转移抑制。
Nat Commun. 2024 Nov 29;15(1):10382. doi: 10.1038/s41467-024-54854-2.
5
Precision oncology revolution: CRISPR-Cas9 and PROTAC technologies unleashed.精准肿瘤学革命:CRISPR-Cas9和PROTAC技术的释放
Front Genet. 2024 Jul 31;15:1434002. doi: 10.3389/fgene.2024.1434002. eCollection 2024.
6
Recent Progress in Photothermal, Photodynamic and Sonodynamic Cancer Therapy: Through the cGAS-STING Pathway to Efficacy-Enhancing Strategies.光热、光动力和超声动力癌症治疗的最新进展:通过 cGAS-STING 通路增强疗效的策略。
Molecules. 2024 Aug 5;29(15):3704. doi: 10.3390/molecules29153704.
7
Conditional PROTAC: Recent Strategies for Modulating Targeted Protein Degradation.条件性 PROTAC:靶向蛋白降解的最新调控策略。
ChemMedChem. 2024 Nov 18;19(22):e202400326. doi: 10.1002/cmdc.202400326. Epub 2024 Sep 18.
8
Targeted Protein Degradation (TPD) for Immunotherapy: Understanding Proteolysis Targeting Chimera-Driven Ubiquitin-Proteasome Interactions.靶向蛋白降解(TPD)在免疫治疗中的作用:了解蛋白水解靶向嵌合体(PROTAC)驱动的泛素-蛋白酶体相互作用。
Bioconjug Chem. 2024 Aug 21;35(8):1089-1115. doi: 10.1021/acs.bioconjchem.4c00253. Epub 2024 Jul 11.
9
NK-92 cells labeled with FeO-PEG-CD56/Avastin@Ce6 nanoprobes for the targeted treatment and noninvasive therapeutic evaluation of breast cancer.用 FeO-PEG-CD56/Avastin@Ce6 纳米探针标记 NK-92 细胞,用于乳腺癌的靶向治疗和无创疗效评估。
J Nanobiotechnology. 2024 Jun 5;22(1):313. doi: 10.1186/s12951-024-02599-x.